Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 7, 2020; 26(33): 4919-4932
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4919
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4919
Figure 3 Potential strategies to shaping the gut microbiota through the “food- gut axis” and enhance immune checkpoint inhibitors’ response.
In order to obtain a favourable microbiota modulation, adjunctive therapeutic strategies, as preparative regimens (via prebiotics, prebiotics, postbiotics or dietary supplementation) could be considered as upcoming ways for improving the efficacy of immunotherapy response. PD-1: Programmed cell death protein 1.
- Citation: Russo E, Nannini G, Dinu M, Pagliai G, Sofi F, Amedei A. Exploring the food-gut axis in immunotherapy response of cancer patients. World J Gastroenterol 2020; 26(33): 4919-4932
- URL: https://www.wjgnet.com/1007-9327/full/v26/i33/4919.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i33.4919